Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS‑addicted cancers. Our R&D pipeline comprises RAS(ON) Inhibitors and RAS Companion Inhibitors designed to suppress oncogenic variants of RAS proteins and enable combination treatment strategies. As we prepare for the launch of new therapies and continued expansion across Europe, we are seeking an experienced Senior Director, Compliance – Europe to p…